These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22052195)

  • 1. The targeted delivery of IL17 to the mouse tumor neo-vasculature enhances angiogenesis but does not reduce tumor growth rate.
    Pasche N; Frey K; Neri D
    Angiogenesis; 2012 Mar; 15(1):165-9. PubMed ID: 22052195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation.
    Frey K; Zivanovic A; Schwager K; Neri D
    Integr Biol (Camb); 2011 Apr; 3(4):468-78. PubMed ID: 21225052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
    Pasche N; Wulhfard S; Pretto F; Carugati E; Neri D
    Clin Cancer Res; 2012 Aug; 18(15):4092-103. PubMed ID: 22693354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeting properties of novel immunocytokines based on murine IL1β and IL6.
    Hess C; Neri D
    Protein Eng Des Sel; 2014 Jun; 27(6):207-13. PubMed ID: 24795343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation.
    Hemmerle T; Zgraggen S; Matasci M; Halin C; Detmar M; Neri D
    J Dermatol Sci; 2014 Nov; 76(2):96-103. PubMed ID: 25190364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7.
    Pasche N; Woytschak J; Wulhfard S; Villa A; Frey K; Neri D
    J Biotechnol; 2011 Jun; 154(1):84-92. PubMed ID: 21527292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.
    Villa A; Trachsel E; Kaspar M; Schliemann C; Sommavilla R; Rybak JN; Rösli C; Borsi L; Neri D
    Int J Cancer; 2008 Jun; 122(11):2405-13. PubMed ID: 18271006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer.
    Hemmerle T; Neri D
    Int J Cancer; 2014 Jan; 134(2):467-77. PubMed ID: 23818211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice.
    Nilsson F; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2001 Jan; 61(2):711-6. PubMed ID: 11212273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel TGF-beta antagonist inhibits tumor growth and angiogenesis by inducing IL-2 receptor-driven STAT1 activation.
    Penafuerte C; Bautista-Lopez N; Bouchentouf M; Birman E; Forner K; Galipeau J
    J Immunol; 2011 Jun; 186(12):6933-44. PubMed ID: 21551368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma.
    Wieckowski S; Hemmerle T; Prince SS; Schlienger BD; Hillinger S; Neri D; Zippelius A
    Lung Cancer; 2015 Apr; 88(1):9-15. PubMed ID: 25682318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth.
    Shen L; Zhu X; Wang Y; Zeng W; Wu G; Xue H; Chen B
    Biol Chem; 2008 Feb; 389(2):135-41. PubMed ID: 18163888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix.
    Carnemolla B; Borsi L; Balza E; Castellani P; Meazza R; Berndt A; Ferrini S; Kosmehl H; Neri D; Zardi L
    Blood; 2002 Mar; 99(5):1659-65. PubMed ID: 11861281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.
    Frischer JS; Huang J; Serur A; Kadenhe-Chiweshe A; McCrudden KW; O'Toole K; Holash J; Yancopoulos GD; Yamashiro DJ; Kandel JJ
    Int J Oncol; 2004 Sep; 25(3):549-53. PubMed ID: 15289855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins.
    Dienst A; Grunow A; Unruh M; Rabausch B; Nör JE; Fries JW; Gottstein C
    J Natl Cancer Inst; 2005 May; 97(10):733-47. PubMed ID: 15900043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
    Sarraf-Yazdi S; Mi J; Moeller BJ; Niu X; White RR; Kontos CD; Sullenger BA; Dewhirst MW; Clary BM
    J Surg Res; 2008 May; 146(1):16-23. PubMed ID: 17950331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.
    Kaspar M; Trachsel E; Neri D
    Cancer Res; 2007 May; 67(10):4940-8. PubMed ID: 17510424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2.
    Oliner J; Min H; Leal J; Yu D; Rao S; You E; Tang X; Kim H; Meyer S; Han SJ; Hawkins N; Rosenfeld R; Davy E; Graham K; Jacobsen F; Stevenson S; Ho J; Chen Q; Hartmann T; Michaels M; Kelley M; Li L; Sitney K; Martin F; Sun JR; Zhang N; Lu J; Estrada J; Kumar R; Coxon A; Kaufman S; Pretorius J; Scully S; Cattley R; Payton M; Coats S; Nguyen L; Desilva B; Ndifor A; Hayward I; Radinsky R; Boone T; Kendall R
    Cancer Cell; 2004 Nov; 6(5):507-16. PubMed ID: 15542434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model.
    Schwager K; Bootz F; Imesch P; Kaspar M; Trachsel E; Neri D
    Hum Reprod; 2011 Sep; 26(9):2344-52. PubMed ID: 21705369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.